Beatriz Duran-Becerra arrived at Columbia University in 2014 and found support and guidance from the Continuing Umbrella of Research Experiences (CURE) program.
Rajshekhar Chakraborty, MD, and Shawn Sarkaria, MD, two new faculty members at Columbia University Irving Medical Center, have joined the Multiple Myeloma Center.
The Human Immune Monitoring Core (HIMC) at CUIMC is a hub for comprehensive immune profiling and expert support for advanced immunological research studies.
Jianlong Wang’s devotion to a career to cancer is personally rooted: He lost his 16-year-old brother to leukemia and has since witnessed other family members and friends succumb to the disease.
There was little known at the time about COVID-19, particularly across patients with different underlying conditions like cancer. What was undeniable was its spread and devastating health effects.
In a new deep analysis of high-grade serous ovarian cancer (HGSOC), researchers have identified a common pathway that could provide a target for new drugs.
Dawn Hershman, MD, MS, joined the faculty at CUIMC in 2001, but her Columbia career dates back to 1994, when she started her residency at the College of Physicians & Surgeons (now VP&S).
